Literature DB >> 4390609

Gas chromatographic identification of thioridazine in plasma, and a method for routine assay of the drug.

S H Curry, G P Mould.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4390609     DOI: 10.1111/j.2042-7158.1969.tb08144.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  7 in total

Review 1.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

2.  Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.

Authors:  F A Vanderheeren; R G Muusze
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

3.  Serum levels of thioridazine in psychiatric patients and healthy volunteers.

Authors:  E Mårtensson; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

4.  Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics.

Authors:  A Carlsson; B E Roos; J Wålinder; A Skott
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

5.  Measurement of thioridazine in blood and urine.

Authors:  C H Ng; J L Crammer
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

6.  Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.

Authors:  A Shvartsburd; V Nwokeafor; R C Smith
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration.

Authors:  J H Jonkman; J Wijsbeek; R A De Zeeuw; L E Van Bork; N G Orie; A M Soeterboek; J Bender
Journal:  Pharm Weekbl Sci       Date:  1982-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.